We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $427.89, moving +2.97% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.05%. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq depreciated by 0.24%.
The largest U.S. health insurer's shares have seen an increase of 8.63% over the last month, surpassing the Medical sector's gain of 4.42% and the S&P 500's loss of 1.42%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 16, 2026. The company's earnings per share (EPS) are projected to be $4.84, reflecting a 18.63% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $110.05 billion, down 1.4% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $18.32 per share and revenue of $443.7 billion, indicating changes of +12.05% and -0.86%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.16% higher. Currently, UnitedHealth Group is carrying a Zacks Rank of #2 (Buy).
In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 22.69. For comparison, its industry has an average Forward P/E of 18.69, which means UnitedHealth Group is trading at a premium to the group.
Investors should also note that UNH has a PEG ratio of 1.67 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - HMOs industry had an average PEG ratio of 1.09 as trading concluded yesterday.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 22, putting it in the top 10% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $427.89, moving +2.97% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.05%. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq depreciated by 0.24%.
The largest U.S. health insurer's shares have seen an increase of 8.63% over the last month, surpassing the Medical sector's gain of 4.42% and the S&P 500's loss of 1.42%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 16, 2026. The company's earnings per share (EPS) are projected to be $4.84, reflecting a 18.63% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $110.05 billion, down 1.4% from the prior-year quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $18.32 per share and revenue of $443.7 billion, indicating changes of +12.05% and -0.86%, respectively, compared to the previous year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.16% higher. Currently, UnitedHealth Group is carrying a Zacks Rank of #2 (Buy).
In terms of valuation, UnitedHealth Group is currently trading at a Forward P/E ratio of 22.69. For comparison, its industry has an average Forward P/E of 18.69, which means UnitedHealth Group is trading at a premium to the group.
Investors should also note that UNH has a PEG ratio of 1.67 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - HMOs industry had an average PEG ratio of 1.09 as trading concluded yesterday.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 22, putting it in the top 10% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.